(Q46514958)

22 December 2017

title

The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure (English)

1 reference

22 December 2017

1 reference

chronic heart failure

1 reference

4

1 reference

22 December 2017

author name string

Klaus K A Witte

1

1 reference

22 December 2017

Simon Thackray

2

1 reference

22 December 2017

Nikolay P Nikitin

3

1 reference

22 December 2017

Andrew L Clark

5

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

European Journal of Heart Failure

published in

1 reference

22 December 2017

volume

7

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

612-617

1 reference

22 December 2017

Exercise limitation in chronic heart failure: central role of the periphery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Is the elevated slope relating ventilation to carbon dioxide production in chronic heart failure a consequence of slow metabolic gas kinetics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Effects of adrenergic stimulation on ventilation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

The selectivity of the beta-adrenoceptor for ventilation in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

The effects of alpha and beta blockade on ventilatory responses to exercise in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Pattern of ventilation during exercise in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Importance of the 'crossover' concept in exercise metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.05.006

10.1016/J.EJHEART.2004.05.006

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017